Pharma News, 2019

GlaxoSmithKline has added continuous manufacturing to its operations in Singapore, a project that allowed it to incorporate new digital technology that will speed production.

A two-week FDA inspection has turned up more issues at the Malaysian manufacturing facilities where Biocon will manufacture its rival to Sanofi's Lantus long-acting insulin.

Scientists at McMaster University have identified new biomarkers for Irritable Bowel Syndrome (IBS) in urine, which could lead to better treatments and reduce the need for costly and invasive ...

Scientists at The University of Toledo investigating improvements to a commonly used chemotherapy drug have discovered an entirely new class of cancer-killing agents that show promise in eradicating c...

For some people, marijuana causes a rewarding high.

Viriom Inc (San Diego, CA) signed a licensing agreement with P.

The European Commission has approved Alexion Pharmaceuticals' Ultomiris (ravulizumab) for the treatment of some adults with the ultra-rare blood disorder paroxysmal nocturnal haemoglobinur...

Shares in Hanmi Pharmaceutical have taken a hit after Johnson & Johnson's Janssen handed back rights to HM12525A, a novel biologic GLP-1/Glucagon dual receptor agonist being developed for weig...

European regulators have approved ViiV Healthcare's Dovato (dolutegravir and lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection.

Vanda Pharmaceuticals is taking legal action against the U.

(Reuters) - Karyopharm Therapeutics Inc on Wednesday set a list-price for its blood cancer treatment Xpovio at $22,000 per month, following accelerated approval from the U.

THOUSAND OAKS, Calif.